Go EuropeAIdirectory

Evidence-backed European AI register

Bioptimus

Reviewed identity, roles, model listings, pricing and evidence for Bioptimus.

Dataset compiled 2026-08-27 · evidence over inference

model lab4 model listings0 token-price rows

Reviewed identity

Headquarters scope
EU headquarters
Headquarters record
Paris
Legal entity
SAS
Ownership
VC-backed private
Founded
2024
Confidence
medium
Last verified
2026-08-22

Links

Official website

Open interactive profile

Evidence boundaries

Organisation listings identify a reviewed canonical record. Model listings show an association in the source register; they do not by themselves establish model creation, current API availability, hosting location or infrastructure ownership.

Model listings

  1. H-optimus-0catalogued with this organisation · origin not asserted
    Type
    image
    Parameters
    1.1B
    Context
    unknown
    Languages
    n/a (histopathology)
    Licence
    open weights (see model card; Apache-2.0 reported)
    Release
    2024-07
  2. H-optimus-1catalogued with this organisation · origin not asserted
    Type
    image
    Parameters
    unknown
    Context
    unknown
    Languages
    n/a
    Licence
    unknown
    Release
    2025
  3. H0-minicatalogued with this organisation · origin not asserted
    Type
    image
    Parameters
    unknown
    Context
    unknown
    Languages
    n/a
    Licence
    unknown
    Release
    2025
  4. M-Optimuscatalogued with this organisation · origin not asserted
    Type
    multimodal
    Parameters
    unknown
    Context
    unknown
    Languages
    n/a
    Licence
    unknown
    Release
    2026-04

Profile note

Founded by ex-Google DeepMind and ex-Owkin scientists to build a universal foundation model for biology. Its H-optimus histopathology models are the leading European open pathology FMs and are widely used as backbones in clinical AI research. Pricing entirely gated.

Record sources

  1. https://www.bioptimus.com/news/bioptimus-launches-h-optimus-0-the-worlds-largest-open-source-ai-foundation-mo…
  2. https://www.bioptimus.com/news/bioptimus-hits-76m-funding
  3. https://aacrjournals.org/cancerres/article/86/8_Supplement/LB174/783174/Abstract-LB174-H-optimus-1-A-foundati…
  4. https://www.bioptimus.com/publications
  5. https://www.bioptimus.com/